Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Edward A. Faber, Jr., DO, MS, is a medical oncologist, hematologist and blood and marrow transplant specialist at OHC. He is a nationally known, published leader in the treatment of blood cancers, with special interest in multiple myeloma and chimeric antigen receptor T-cell therapy (CAR-T). Dr. Faber is actively involved in clinical research and serves as a principal investigator for OHC’s multiple myeloma clinical trials.
Dr. Faber received his medical degree from Lake Erie College of Osteopathic Medicine, Erie, PA. He completed his residency at the University of Pittsburgh Medical Center – Mercy Hospital, Pittsburgh, PA and a fellowship at Michigan State University, Lansing, MI. He also received a Master of Science in Genetics and Molecular Biology from Duquesne University, Pittsburgh, PA and a Certiﬁcate in Healthcare Management from Pennsylvania State University, Behrend College in State College, PA.
Dr. Faber is board certiﬁed in internal medicine, medical oncology and hematology by the American Board of Internal Medicine.
Dr. Faber’s extensive clinical knowledge and experience is matched only by his compassion for his patients. “The most rewarding part of my job is the close relationships I form with my patients and their families. I consider it a privilege to care for them as they deal with the difﬁcult diagnosis of cancer.”